Peripheral artery disease (PAD) can lead to gangrene or amputation yet is often overlooked - experts have warned that just ...

A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million ...

this time building its positions in peripheral artery disease (PAD) and with an oral formulation, based on two major studies. In the randomized STRIDE trial, a year of semaglutide (Ozempic ...

The treatment of many patients with peripheral artery disease is not optimal, and indeed is much worse than that in patients ...

Other symptoms may mimic signs of poor circulation like pins and needles, cold extremities, pale or blue skin, muscle ...

Treatment with semaglutide improved maximum walking distance in patients with type 2 diabetes (T2D) and symptomatic peripheral artery disease (PAD), according to results from the STRIDE trial ...

A simple blood test and imaging studies can confirm the presence of PAD and guide appropriate treatment. Cold hands might seem harmless, but they could be a red flag for Peripheral Artery Disease ...

Eli Lilly’s experimental drug, lepodisiran, reduces lipoprotein(a) (Lp[a]) levels by an average of 93.9 per cent in a ...

Within one-year of treatment, patients taking semaglutide ... Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b ...

Did you know men and women's heart cells prefer different kinds of fuel? Gender differences are emerging as scientists turn ...

A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million Americans over the age of 40, is often underdiagnosed and undertreated, with fewer ...